Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces the risk of major cardiovascular events, such as heart a

Ozempic and similar drugs are popular with consumers for their weight-loss properties, but a new study suggests they could have a harmful side effect that

A recent study suggests a potential link between Ozempic and vision loss, particularly non-arteritic anterior ischemic optic neuropathy (NAION), raising concerns about rapid blood sugar reduction affecting eye health.